1 Herrmann J, "The ubiquitin-proteasome system in cardiovascular diseases : a hypothesis extended" 61 : 11-21, 2004
2 Marfella R, "The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes" 6 : 35-, 2007
3 Wilck N, "Targeting the ubiquitin-proteasome system in atherosclerosis: status quo, challenges, and perspectives" 21 : 2344-2363, 2014
4 Bochmann I, "T lymphocytes export proteasomes by way of microparticles : a possible mechanism for generation of extracellular proteasomes" 18 : 59-68, 2014
5 Wu M, "Sustained oxidative stress inhibits NF-kappaB activation partially via inactivating the proteasome" 46 : 62-69, 2009
6 Russell JC, "Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis" 15 : 318-330, 2006
7 Dhanya SP, "Small animal models of atherosclerosis" 6 : e4-, 2008
8 Stocker R, "Role of oxidative modifications in atherosclerosis" 84 : 1381-1478, 2004
9 Van Herck JL, "Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice" 105 : 39-50, 2010
10 Vieira O, "Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway : potential role in oxidized LDL-induced apoptosis" 14 : 532-542, 2000
1 Herrmann J, "The ubiquitin-proteasome system in cardiovascular diseases : a hypothesis extended" 61 : 11-21, 2004
2 Marfella R, "The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes" 6 : 35-, 2007
3 Wilck N, "Targeting the ubiquitin-proteasome system in atherosclerosis: status quo, challenges, and perspectives" 21 : 2344-2363, 2014
4 Bochmann I, "T lymphocytes export proteasomes by way of microparticles : a possible mechanism for generation of extracellular proteasomes" 18 : 59-68, 2014
5 Wu M, "Sustained oxidative stress inhibits NF-kappaB activation partially via inactivating the proteasome" 46 : 62-69, 2009
6 Russell JC, "Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis" 15 : 318-330, 2006
7 Dhanya SP, "Small animal models of atherosclerosis" 6 : e4-, 2008
8 Stocker R, "Role of oxidative modifications in atherosclerosis" 84 : 1381-1478, 2004
9 Van Herck JL, "Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice" 105 : 39-50, 2010
10 Vieira O, "Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway : potential role in oxidized LDL-induced apoptosis" 14 : 532-542, 2000
11 Hermann J, "Oxidative stress-related increase in ubiquitination in early coronary atherogenesis" 17 : 1730-1732, 2003
12 Herrmann J, "On to the road to degradation : atherosclerosis and the proteasome" 85 : 291-302, 2010
13 Dąbek J, "Nuclear factor kappa-lightchain-enhancer of activated B cells (NF-kappaB): a new potential therapeutic target in atherosclerosis?" 62 : 778-783, 2010
14 Bennani-Kabchi N, "New model of atherosclerosis in insulin resistant sand rats : hypercholesterolemia combined with D2vitamin" 150 : 55-61, 2000
15 Tan C, "Inhibition of the ubiquitinproteasome system : a new avenue for atherosclerosis" 44 : 1218-1225, 2006
16 Kikuchi J, "Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis" 20 : 128-134, 2000
17 Marfella R, "Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque : effects of rosiglitazone treatment" 47 : 2444-2455, 2006
18 Pang J, "Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat" 31 : 630-638, 2010
19 Lloyd-Jones D, "Heart disease and stroke statistics: 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee" 119 : e21-e181, 2009
20 Sixt SU, "Extracellular proteasome in the human alveolar space: a new housekeeping enzyme?" 292 : L1280-L1288, 2007
21 Li J, "Effects of total glucosides from paeony(Paeonia lactiflora Pall)roots on experimental atherosclerosis in rats" 135 : 469-475, 2011
22 Davis HR Jr, "Effects of ezetimibe on atherosclerosis in preclinical models" 215 : 266-278, 2011
23 Vinitha R, "Effect of tamoxifen on lipids and lipid metabolising marker enzymes in experimental atherosclerosis in Wistar rats" 168 : 13-19, 1997
24 Srivastava RA, "Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism" 267 : 4272-4280, 2000
25 Murwani S, "Diet aterogenik pada tikus putih(Rattus novergicus strain Wistar)sebagai model hewan aterosklerosis" 22 : 6-12, 2006
26 Bellavista E, "Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis" 2014 : 739705-, 2014
27 World Health Organization, "Cardiovascular diseases fact sheet" World Health Organization
28 Pyle AL, "Atheromas feel the pressure : biomechanical stress and atherosclerosis" 177 : 4-9, 2010
29 Fonarow GC, "Aggressive treatment of atherosclerosis: the time is now" 70 : 431-434, 2003
30 Stary HC, "A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association" 92 : 1355-1374, 1995
31 Doaa M. Abo El-Khair, "A comparative study on the effect of high cholesterol diet on the hippocampal CA1 area of adult and aged rats" 대한해부학회 47 (47): 117-126, 2014